AHCO
AdaptHealth Corp. Healthcare - Medical Devices Investor Relations →
AdaptHealth Corp. (AHCO) closed at $9.91 as of 2026-03-20, trading 18.0% below its 200-week moving average of $12.08. This places AHCO in the extreme value zone. The stock is currently moving closer to the line, down from -12.6% last week. The 14-week RSI sits at 47, indicating neutral momentum.
Trading volume is running at 1.6x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.86 ratio) is neutral — neither side is clearly dominating.
Over the past 359 weeks of data, AHCO has crossed below its 200-week moving average 6 times. On average, these episodes lasted 32 weeks. Historically, investors who bought AHCO at the start of these episodes saw an average one-year return of +16.5%.
With a market cap of $1347 million, AHCO is a small-cap stock. The company generates a free cash flow yield of 18.3%, which is notably high. Return on equity stands at -4.3%. The stock trades at 0.9x book value.
This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.
Over the past 6.9 years, a hypothetical investment of $100 in AHCO would have grown to $98, compared to $262 for the S&P 500. AHCO has returned -0.3% annualized vs 14.9% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 3 open-market purchases totaling $20,028,378. Multiple insiders purchased within a 30-day window — a cluster buy pattern that historically signals management confidence in the company's prospects. Notably, these purchases occurred while AHCO is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: AHCO vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After AHCO Crosses Below the Line?
Across 6 historical episodes, buying AHCO when it crossed below its 200-week moving average produced an average return of +21.7% after 12 months (median -33.0%), compared to +17.2% for the S&P 500 over the same periods. 33% of those episodes were profitable after one year. After 24 months, the average return was -15.8% vs +47.7% for the index.
Each line shows $100 invested at the moment AHCO crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
AHCO has crossed below its 200-week MA 6 times with an average 1-year return of +16.5% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Nov 2019 | Dec 2019 | 5 | 13.9% | +209.0% | +2.1% |
| Jan 2022 | Jul 2022 | 23 | 30.0% | +18.6% | -44.5% |
| Aug 2022 | Sep 2022 | 1 | 7.2% | -32.9% | -43.6% |
| Sep 2022 | Oct 2022 | 1 | 1.8% | -51.5% | -47.2% |
| Dec 2022 | Jan 2023 | 4 | 3.5% | -60.8% | -49.8% |
| Feb 2023 | Ongoing | 160+ | 66.5% | Ongoing | -38.1% |
| Average | 32 | — | +16.5% | — |
Frequently Asked Questions
Is AHCO below its 200-week moving average?
Yes. As of 2026-03-20, AdaptHealth Corp. (AHCO) is trading 18.0% below its 200-week moving average of $12.08. The current price is $9.91.
What is AHCO's 200-week moving average price?
AdaptHealth Corp.'s 200-week moving average is $12.08 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when AHCO drops below its 200-week moving average?
AHCO has crossed below its 200-week moving average 6 times in our data. On average, buying at that moment produced a one-year return of +16.5%. These dips have historically been decent entry points. These episodes lasted 32 weeks on average.
Is AHCO a good value right now?
Here's what our data says about AHCO as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 47. Free cash flow yield is 18.3%. Return on equity is -4.3%. Price-to-book is 0.9x. This is not a buy or sell recommendation — always do your own research.
How does AHCO compare to the S&P 500?
Over the past 6.9 years, $100 invested in AHCO would have grown to $98, compared to $262 for the S&P 500. That's -0.3% annualized vs 14.9% for the index. AHCO has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20